Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F46WZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,773
Award facts
- Contract value 100% obligated
- $16,773.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a contract ceiling value of $16,773.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The performance location is identified as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 31, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's substantial IDC with the DLA functions as a comprehensive global pharmaceutical support vehicle, enabling delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The current delivery order for Eliquis, a widely prescribed anticoagulant medication, demonstrates AmerisourceBergen's ongoing role in supplying essential pharmaceuticals through the DLA's medical supply chain to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F46WZ?
SPE2DR26F46WZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F46WZ worth?
The government has obligated $16,773 on SPE2DR26F46WZ.
Is contract SPE2DR26F46WZ an order under another contract?
Yes. SPE2DR26F46WZ is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F46WZ competed?
The extent of competition for SPE2DR26F46WZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award